Literature DB >> 10737982

SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.

A Noguchi1, Y Shoji, A Koizumi, T Takahashi, M Matsumori, T Kayo, T Ohata, Y Wada, I Yoshimura, S Maisawa, M Konishi, Y Takasago, G Takada.   

Abstract

Lysinuric protein intolerance (LPI) is a rare inherited disease caused by defective transport of the dibasic amino acids at the basolateral membranes of epithelial cells in the renal tubules and small intestine. The metabolic defect leads to brain dysfunction caused by hyperammonemia with a functional impairment of the urea cycle. Recently, mutations in the human SLC7A7 cDNA coding for y(+)LAT-1, which express dibasic amino acid transport activity, were reported to be responsible for LPI. In the present study, we examined the genomic structure of SLC7A7 by DNA sequencing of PCR products, and determined that the gene had 11 exons and 10 introns spanning about 18 kb of genomic DNA. We also identified an alternative RNA splicing at the 5' untranslated region of the SLC7A7 mRNA in human peripheral blood leukocytes, cultured lymphoblasts, and fibroblasts. As a result of mutational analysis of SLC7A7 in three Japanese LPI families, we found a nonsense mutation (R410X), a splicing mutation(911+1G>A) in intron 4, and four silent polymorphisms (201C/T, 445A/G, 784C/T, 946T/C). Identification of the genomic structure of SLC7A7 may provide a molecular basis for a genetic survey for LPI. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737982     DOI: 10.1002/(SICI)1098-1004(200004)15:4<367::AID-HUMU9>3.0.CO;2-C

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Impaired portal circulation resulting from L-arginine deficiency in patients with lysinuric protein intolerance.

Authors:  T Takeda; H Watanabe; T Saito; K Saito; H Takeda; H Togashi; J Fujii; Y Takasago; S Kawata
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 3.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

4.  Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.

Authors:  Mariona Font-Llitjós; Benjamín Rodríguez-Santiago; Meritxell Espino; Ruth Sillué; Sandra Mañas; Laia Gómez; Luis A Pérez-Jurado; Manuel Palacín; Virginia Nunes
Journal:  Eur J Hum Genet       Date:  2008-08-20       Impact factor: 4.246

5.  The first Korean case of lysinuric protein intolerance: presented with short stature and increased somnolence.

Authors:  Jung Min Ko; Choong Ho Shin; Sei Won Yang; Moon Woo Seong; Sung Sup Park; Junghan Song
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

6.  New mutations in the SLC7A7 gene of two chinese sisters with lysinuric protein intolerance.

Authors:  Guoqing Zhang; Ling Cao
Journal:  Pediatr Pulmonol       Date:  2017-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.